Welcome to BOPA
Latest news from BOPA
BOPA Committee would like to congratulate Jackie Lewis on her award
Unafraid to explore areas traditionally outside the remit of community pharmacy, Lewis Pharmacy has made a huge difference to its local community. Its service to cancer patients is a prime example of this approach. Despite cancer typically being the domain of secondary care, the pharmacy team has been determined to make a difference to this group of patients. Not only does it offer in-depth MURs to customers on cancer-related medication, it has also worked with the hospital, local charities and GPs to offer a seamless network of support.
Well done Jackie!Read More
The RPS Faculty has just celebrated its two year anniversary, and as an affiliated partner BOPA continues with development of curricula. The cancer curriculum has been reviewed to include mastery level, in line with other RPS curricula, by the BOPA credentialing & professional development subcommittee. This specialist curriculum should be used alongside the Advanced Pharmacy Framework.
The updated version can be found in the document repository on the BOPA website: http://www.bopawebsite.org/repository/
First Early Access to Medicines (EAMS) Scientific Opinion issued by MHRA
The MHRA has issued its first Early Access to Medicines (EAMS) scientific opinion.
It is for a product called pembrolizumab, used to treat advanced melanoma which has spread or cannot be removed by surgery and has progressed after other treatments. The MHRA assessment team considered that pembrolizumab had been shown to slow the progression of cancer in a condition where other treatments currently have poor results.
Details of the scientific opinion (https://www.gov.uk/government/publications/early-access-to-medicines-scheme-eams-scientific-opinion-pembrolizumab-mk-3475) can be found on the MHRA website, as well as background information on EAMS (https://www.gov.uk/apply-for-the-early-access-to-medicines-scheme-eams).